Juyong Bong, MD
Family Practice · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 11 years
- Texas A & M University System, Hsc, College of Medicine, 2015
Offices
3 locations · Smartcare Medical Group, Inc · Vitalize Behavioral Health and Psychometrics Inc. · Community Health Partners
Hospitals listed: 057248 · A01798 · Clovis Community Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bong’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A170483 · Current
Licensed to practise in California · since 2020 · expires 2028-10-31 · Texas A & M University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$103,252
Medicare paid this office $103,252 for 352 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 156 | $42,038 | $136 |
| Return visit (30+ min) | 163 | $25,761 | $98 |
| Short return visit (20+ min) | 148 | $11,776 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $8,225 | $135 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 169 | $5,424 | $13 |
See all 9 services
| Long return visit (40+ min) | 156 | $42,038 | $136 |
| Return visit (30+ min) | 163 | $25,761 | $98 |
| Short return visit (20+ min) | 148 | $11,776 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $8,225 | $135 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 169 | $5,424 | $13 |
| New patient visit (45+ min) | 19 | $2,417 | $127 |
| New patient visit (60+ min) | 13 | $1,987 | $153 |
| New patient visit (30+ min) | 23 | $1,477 | $64 |
| Annual depression screening, 5 to 15 minutes | 40 | $804 | $20 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
352 Original Medicare patients in 2024. Average age 76 · Women 51% · Also on Medicaid 7% · Health risk score 1.07. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Chronic kidney disease 33% · Coronary heart disease 30% · Diabetes 28% · Atrial fibrillation 19% · Depression 18% · Cancer 15% · Heart failure 14% · Stroke 8% · COPD 7% · Dementia 5%.
The office billed $346,777, Medicare allowed $138,071 and paid $103,252; for 1,434 services of 36 kinds; $706 of it was for drugs given in the office and $102,546 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 352 | 1,434 | 76 | 1.07 | $346,777 | $103,252 |
| 2023 | 322 | 881 | 76 | 1.19 | $213,600 | $62,335 |
| 2022 | 174 | 371 | 76 | 1.07 | $78,074 | $29,655 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 244 | $21,225 | $61 |
| Long return visit (40+ min) | 84 | $14,317 | $129 |
| Return visit (30+ min) | 81 | $8,532 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $8,047 | $132 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 31 | $2,485 | $75 |
| New patient visit (45+ min) | 12 | $1,044 | $87 |
| Administration of influenza virus vaccine | 31 | $1,036 | $31 |
| New patient visit (30+ min) | 17 | $986 | $58 |
| Annual depression screening, 5 to 15 minutes | 20 | $384 | $19 |
| Short return visit | 15 | $370 | $25 |
2022: 5 services
| Return visit (30+ min) | 79 | $9,022 | $100 |
| Short return visit (20+ min) | 95 | $8,126 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,157 | $134 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 39 | $2,740 | $70 |
| Administration of influenza virus vaccine | 40 | $1,229 | $31 |
Drugs they prescribed that Part D paid
$452,769
Pharmacies billed $452,769 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (233 of 5,311) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 8% of their opioid prescriptions.
4,668 generic and 602 brand-name prescriptions · $452,769 in drug cost · 149 antibiotic prescriptions to 114 people · 26 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 52 | $67,033 | $1,289 |
| Eliquis | 60 | $62,565 | $1,043 |
| Farxiga | 24 | $28,570 | $1,190 |
| Trulicity | 17 | $25,169 | $1,481 |
| Ozempic | 20 | $19,505 | $975 |
See all 112 drugs
| Jardiance | 52 | $67,033 | $1,289 |
| Eliquis | 60 | $62,565 | $1,043 |
| Farxiga | 24 | $28,570 | $1,190 |
| Trulicity | 17 | $25,169 | $1,481 |
| Ozempic | 20 | $19,505 | $975 |
| Januvia | 11 | $16,816 | $1,529 |
| Xarelto | 16 | $16,573 | $1,036 |
| Trelegy Ellipta | 11 | $7,753 | $705 |
| Levothyroxine | 256 | $4,520 | $18 |
| Buprenorphine | 15 | $4,157 | $277 |
| Atorvastatin | 329 | $4,108 | $12 |
| Lantus Solostar | 28 | $3,729 | $133 |
| Arnuity Ellipta | 11 | $2,701 | $246 |
| Metoprolol | 150 | $2,404 | $16 |
| Pregabalin | 25 | $2,129 | $85 |
| Gabapentin | 154 | $2,062 | $13 |
| Albuterol Sulfate Hfa | 77 | $1,976 | $26 |
| Ezetimibe | 45 | $1,968 | $44 |
| Tamsulosin | 96 | $1,905 | $20 |
| Losartan | 154 | $1,683 | $11 |
| Celecoxib | 23 | $1,665 | $72 |
| Lisinopril | 187 | $1,649 | $9 |
| Estradiol | 21 | $1,544 | $74 |
| Rosuvastatin | 122 | $1,417 | $12 |
| Fluticasone-Salmeterol | 11 | $1,389 | $126 |
| Memantine | 24 | $1,298 | $54 |
| Trazodone | 101 | $1,295 | $13 |
| Omeprazole | 105 | $1,281 | $12 |
| Tizanidine | 29 | $1,269 | $44 |
| Hydrocodone-Acetaminophen | 85 | $1,095 | $13 |
| Pantoprazole | 73 | $1,007 | $14 |
| Allopurinol | 35 | $970 | $28 |
| Duloxetine | 43 | $921 | $21 |
| Potassium Chloride | 24 | $887 | $37 |
| Fenofibrate | 20 | $828 | $41 |
| Liothyronine | 14 | $823 | $59 |
| Olmesartan Medoxomil | 20 | $810 | $40 |
| Valsartan-Hydrochlorothiazide | 19 | $796 | $42 |
| Amlodipine Besylate | 109 | $763 | $7 |
| Fenofibrate | 13 | $763 | $59 |
| Metformin | 70 | $758 | $11 |
| Esomeprazole Magnesium | 19 | $750 | $39 |
| Sertraline | 81 | $729 | $9 |
| Ondansetron Odt | 26 | $716 | $28 |
| Pioglitazone | 32 | $665 | $21 |
| Lantus | 11 | $645 | $59 |
| Clonidine | 11 | $642 | $58 |
| Bupropion Xl | 41 | $622 | $15 |
| Diclofenac | 35 | $613 | $18 |
| Simvastatin | 57 | $594 | $10 |
| Escitalopram | 35 | $587 | $17 |
| Bupropion Hcl Sr | 14 | $531 | $38 |
| Montelukast | 39 | $530 | $14 |
| Mirtazapine | 17 | $513 | $30 |
| Valacyclovir | 18 | $509 | $28 |
| Valsartan | 17 | $474 | $28 |
| Carbidopa-Levodopa | 15 | $472 | $31 |
| Finasteride | 29 | $462 | $16 |
| Levetiracetam | 17 | $456 | $27 |
| Fluticasone Propionate | 42 | $443 | $11 |
| Tramadol | 98 | $417 | $4 |
| Alendronate | 37 | $413 | $11 |
| Testosterone Cypionate | 15 | $401 | $27 |
| Glipizide | 13 | $399 | $31 |
| Donepezil | 28 | $386 | $14 |
| Metformin Hcl Er | 47 | $361 | $8 |
| Lisinopril-Hydrochlorothiazide | 36 | $358 | $10 |
| Fluoxetine | 16 | $312 | $20 |
| Buspirone | 27 | $312 | $12 |
| Nortriptyline | 11 | $309 | $28 |
| Metoprolol | 35 | $280 | $8 |
| Cyclobenzaprine | 40 | $280 | $7 |
| Hydrochlorothiazide | 81 | $279 | $3 |
| Furosemide | 53 | $276 | $5 |
| Azithromycin | 65 | $261 | $4 |
| Nitrofurantoin Mono-Macro | 19 | $243 | $13 |
| Amitriptyline | 18 | $242 | $13 |
| Benazepril | 23 | $237 | $10 |
| Diltiazem 24hr Er (Cd) | 11 | $235 | $21 |
| Losartan-Hydrochlorothiazide | 20 | $231 | $12 |
| Carvedilol | 33 | $227 | $7 |
| Meloxicam | 32 | $224 | $7 |
| Pravastatin | 14 | $220 | $16 |
| Azelastine | 11 | $212 | $19 |
| Temazepam | 14 | $190 | $14 |
| Atenolol | 26 | $188 | $7 |
| Clopidogrel | 19 | $187 | $10 |
| Propranolol | 23 | $183 | $8 |
| Nystatin | 13 | $161 | $12 |
| Glipizide Er | 12 | $161 | $13 |
| Oxybutynin Chloride | 17 | $152 | $9 |
| Famotidine | 11 | $148 | $13 |
| Sumatriptan | 15 | $146 | $10 |
| Oxycodone | 12 | $144 | $12 |
| Zolpidem | 18 | $142 | $8 |
| Lorazepam | 18 | $142 | $8 |
| Spironolactone | 15 | $140 | $9 |
| Ibuprofen | 29 | $134 | $5 |
| Ramipril | 13 | $125 | $10 |
| Prednisone | 65 | $121 | $2 |
| Ondansetron | 11 | $111 | $10 |
| Cephalexin | 19 | $110 | $6 |
| Citalopram Hbr | 12 | $105 | $9 |
| Triamterene-Hydrochlorothiazid | 15 | $98 | $7 |
| Alprazolam | 18 | $96 | $5 |
| Hydralazine | 14 | $86 | $6 |
| Ciprofloxacin | 18 | $86 | $5 |
| Meclizine | 20 | $81 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $78 | $7 |
| Clonazepam | 35 | $73 | $2 |
| Hydroxyzine | 13 | $70 | $5 |
| Triamcinolone Acetonide | 11 | $63 | $6 |
Year by year
| 2024 | 5,311 | 557 | 4% (233) | 11% | $452,769 |
| 2023 | 3,264 | 490 | 4% (126) | 13% | $342,444 |
| 2022 | 543 | 182 | 3% (18) | None | $40,504 |
| 2021 | 152 | 31 | None | 23% | $14,109 |
| 2020 | 87 | 14 | None | 24% | $3,445 |
| 2019 | 30 | None | 0% (0) | None | $1,723 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 75 drugs
| Eliquis | 47 | $49,716 | $1,058 |
| Jardiance | 33 | $40,909 | $1,240 |
| Farxiga | 17 | $25,179 | $1,481 |
| Ozempic | 16 | $19,140 | $1,196 |
| Lantus Solostar | 22 | $14,976 | $681 |
| Repatha Sureclick | 14 | $10,861 | $776 |
| Atorvastatin | 211 | $3,159 | $15 |
| Levothyroxine | 165 | $2,686 | $16 |
| Febuxostat | 12 | $2,316 | $193 |
| Icosapent Ethyl | 11 | $1,971 | $179 |
| Albuterol Sulfate Hfa | 44 | $1,857 | $42 |
| Losartan | 105 | $1,828 | $17 |
| Tamsulosin | 64 | $1,744 | $27 |
| Metoprolol | 84 | $1,741 | $21 |
| Gabapentin | 84 | $1,509 | $18 |
| Celecoxib | 14 | $1,446 | $103 |
| Rosuvastatin | 81 | $1,361 | $17 |
| Lisinopril | 112 | $1,260 | $11 |
| Ezetimibe | 29 | $1,259 | $43 |
| Potassium Chloride | 27 | $1,086 | $40 |
| Diclofenac | 43 | $1,076 | $25 |
| Bupropion Xl | 19 | $934 | $49 |
| Hydrocodone-Acetaminophen | 56 | $877 | $16 |
| Pantoprazole | 63 | $854 | $14 |
| Omeprazole | 44 | $854 | $19 |
| Estradiol | 12 | $791 | $66 |
| Trazodone | 59 | $740 | $13 |
| Pregabalin | 15 | $734 | $49 |
| Amlodipine Besylate | 66 | $730 | $11 |
| Valsartan-Hydrochlorothiazide | 12 | $714 | $59 |
| Fenofibrate | 15 | $702 | $47 |
| Nitrofurantoin Mono-Macro | 30 | $674 | $22 |
| Bupropion Hcl Sr | 11 | $671 | $61 |
| Montelukast | 29 | $624 | $22 |
| Sertraline | 36 | $555 | $15 |
| Doxepin | 22 | $537 | $24 |
| Esomeprazole Magnesium | 12 | $516 | $43 |
| Metformin | 35 | $509 | $15 |
| Escitalopram | 21 | $500 | $24 |
| Duloxetine | 21 | $493 | $23 |
| Temazepam | 13 | $477 | $37 |
| Fluticasone Propionate | 33 | $471 | $14 |
| Metformin Hcl Er | 33 | $388 | $12 |
| Hydrochlorothiazide | 56 | $388 | $7 |
| Clopidogrel | 19 | $373 | $20 |
| Metoprolol | 42 | $366 | $9 |
| Tramadol | 53 | $364 | $7 |
| Donepezil | 15 | $361 | $24 |
| Ondansetron Odt | 15 | $349 | $23 |
| Furosemide | 49 | $348 | $7 |
| Levetiracetam | 14 | $338 | $24 |
| Mirtazapine | 13 | $328 | $25 |
| Carvedilol | 17 | $315 | $19 |
| Allopurinol | 26 | $303 | $12 |
| Finasteride | 15 | $284 | $19 |
| Simvastatin | 26 | $281 | $11 |
| Azithromycin | 48 | $268 | $6 |
| Alendronate | 22 | $245 | $11 |
| Atenolol | 22 | $243 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $243 | $20 |
| Lisinopril-Hydrochlorothiazide | 24 | $230 | $10 |
| Ondansetron | 14 | $198 | $14 |
| Clonazepam | 21 | $193 | $9 |
| Citalopram Hbr | 14 | $143 | $10 |
| Pravastatin | 14 | $140 | $10 |
| Hydroxyzine | 14 | $139 | $10 |
| Acetaminophen-Codeine | 13 | $121 | $9 |
| Prednisone | 53 | $100 | $2 |
| Ibuprofen | 18 | $94 | $5 |
| Cyclobenzaprine | 14 | $93 | $7 |
| Lorazepam | 11 | $91 | $8 |
| Zolpidem | 12 | $77 | $6 |
| Alprazolam | 12 | $76 | $6 |
| Ciprofloxacin | 13 | $69 | $5 |
| Amoxicillin | 14 | $49 | $3 |
2022: 8 drugs
| Rosuvastatin | 15 | $527 | $35 |
| Levothyroxine | 26 | $439 | $17 |
| Atorvastatin | 35 | $386 | $11 |
| Losartan | 20 | $324 | $16 |
| Gabapentin | 18 | $285 | $16 |
| Trazodone | 13 | $171 | $13 |
| Amlodipine Besylate | 14 | $114 | $8 |
| Escitalopram | 11 | $113 | $10 |
Money from drug and device companies
$2,040 in 2025
| 2025 | 27 | 112 | None | $2,040 |
| 2024 | 27 | 128 | None | $1,928 |
| 2023 | 27 | 120 | None | $1,809 |
| 2022 | 13 | 28 | None | $473 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $457 | 24 payments
|
| Novo Nordisk | Ozempic | $303 | 15 payments
|
| Amgen | Otezla | $165 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $160 | 4 payments
|
| GlaxoSmithKline | Shingrix | $143 | 10 payments
|
| Axsome Therapeutics | Auvelity | $105 | 4 payments
|
See all 100 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-18 | Kerendia | $23 |
| Novo Nordisk | Meals · 2025-12-17 | Ozempic | $8 |
| Axsome Therapeutics | Meals · 2025-12-14 | Symbravo | $34 |
| Abbvie | Meals · 2025-12-09 | Vraylar | $25 |
| Abbvie | Meals · 2025-12-08 | Vraylar | $14 |
| Abbvie | Meals · 2025-12-06 | Ubrelvy | $8 |
| Exact Sciences | Meals · 2025-12-03 | Cologuard Collection Kit | $19 |
| Novo Nordisk | Meals · 2025-11-19 | Wegovy | $24 |
| Recordati Rare Diseases Inc. | Meals · 2025-11-18 | Isturisa | $25 |
| GlaxoSmithKline | Meals · 2025-11-18 | Shingrix | $20 |
| Abbvie | Meals · 2025-11-13 | Vraylar | $1 |
| Abbvie | Meals · 2025-11-13 | Vraylar | $15 |
| Amgen | Meals · 2025-11-11 | Otezla | $16 |
| Amgen | Meals · 2025-11-11 | Evenity | $17 |
| Novo Nordisk | Meals · 2025-11-10 | Ozempic | $19 |
| GlaxoSmithKline | Meals · 2025-11-03 | Trelegy Ellipta | $10 |
| Gilead Sciences | Meals · 2025-10-29 | Yeztugo | $101 |
| Amgen | Meals · 2025-10-28 | Evenity | $16 |
| Sumitomo Pharma America | Meals · 2025-10-27 | Gemtesa | $18 |
| Abbvie | Meals · 2025-10-22 | Vraylar | $24 |
| Abbvie | Meals · 2025-10-22 | Vraylar | $24 |
| Abbvie | Meals · 2025-10-15 | Vraylar | $13 |
| Radius Health | Meals · 2025-10-15 | None | $16 |
| Amgen | Meals · 2025-10-01 | Otezla | $17 |
| Sumitomo Pharma America | Meals · 2025-09-25 | Gemtesa | $17 |
| Abbvie | Meals · 2025-09-25 | Ubrelvy | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-24 | Breztri | $24 |
| Abbvie | Meals · 2025-09-18 | Ubrelvy | $26 |
| Radius Health | Meals · 2025-09-13 | None | $25 |
| Amgen | Meals · 2025-09-11 | Repatha | $15 |
| Xeris Pharmaceuticals | Meals · 2025-09-11 | Recorlev | $20 |
| Novo Nordisk | Meals · 2025-09-08 | Ozempic | $6 |
| GlaxoSmithKline | Meals · 2025-09-04 | Shingrix | $16 |
| Amgen | Meals · 2025-08-28 | Otezla | $12 |
| Abbvie | Meals · 2025-08-26 | Vraylar | $22 |
| Verity Pharmaceuticals | Meals · 2025-08-18 | Tlando | $29 |
| GlaxoSmithKline | Meals · 2025-08-13 | Shingrix | $18 |
| Novo Nordisk | Meals · 2025-08-06 | Ozempic | $29 |
| Abiomed | Meals · 2025-08-05 | None | $25 |
| Abbvie | Meals · 2025-07-31 | Vraylar | $25 |
| Novo Nordisk | Meals · 2025-07-23 | Ozempic | $18 |
| Amgen | Meals · 2025-07-22 | Otezla | $18 |
| Axsome Therapeutics | Meals · 2025-07-22 | Auvelity | $27 |
| Aimmune Therapeutics | Meals · 2025-07-15 | Zenpep | $18 |
| Novo Nordisk | Meals · 2025-07-11 | Wegovy | $25 |
| Abbvie | Meals · 2025-07-09 | Ubrelvy | $8 |
| Merck Sharp & Dohme | Meals · 2025-07-09 | None | $21 |
| Sumitomo Pharma America | Meals · 2025-07-07 | Gemtesa | $16 |
| ViiV Healthcare | Meals · 2025-07-03 | Cabenuva | $17 |
| Abbvie | Meals · 2025-07-02 | Vraylar | $25 |
| Amgen | Meals · 2025-06-23 | Repatha | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-18 | Airsupra | $19 |
| Axsome Therapeutics | Meals · 2025-06-17 | Auvelity | $28 |
| Dexcom | Meals · 2025-06-16 | Dexcom G6 Transmitter | $17 |
| GlaxoSmithKline | Meals · 2025-06-13 | Trelegy Ellipta | $11 |
| GlaxoSmithKline | Meals · 2025-06-11 | Shingrix | $16 |
| Novo Nordisk | Meals · 2025-06-10 | None | $27 |
| GlaxoSmithKline | Meals · 2025-06-06 | Trelegy Ellipta | $17 |
| Abbvie | Meals · 2025-06-04 | Vraylar | $31 |
| Pfizer | Meals · 2025-06-04 | Nurtec Odt | $24 |
| Abbvie | Meals · 2025-05-28 | Qulipta | $7 |
| Lilly USA | Meals · 2025-05-26 | Jardiance | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-22 | Farxiga | $34 |
| Abbvie | Meals · 2025-05-21 | Vraylar | $21 |
| Amgen | Meals · 2025-05-20 | Otezla | $21 |
| Novo Nordisk | Meals · 2025-05-14 | Ozempic | $30 |
| Novo Nordisk | Meals · 2025-05-12 | Ozempic | $7 |
| GlaxoSmithKline | Meals · 2025-05-12 | Shingrix | $17 |
| Abbvie | Meals · 2025-05-08 | Synthroid | $17 |
| Sumitomo Pharma America | Meals · 2025-05-02 | Gemtesa | $17 |
| Otsuka America Pharmaceutical | Meals · 2025-04-29 | Rexulti | $25 |
| Lundbeck | Meals · 2025-04-28 | Rexulti | $19 |
| Abbvie | Meals · 2025-04-24 | Vraylar | $29 |
| Novo Nordisk | Meals · 2025-04-22 | Ozempic | $22 |
| Novo Nordisk | Meals · 2025-04-22 | None | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-04-10 | Rexulti | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-09 | Caplyta | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-07 | None | $18 |
| Becton Dickinson and | Meals · 2025-04-05 | Rotarexs 6 F X 135 Cm | $18 |
| Novo Nordisk | Meals · 2025-03-26 | None | $25 |
| GlaxoSmithKline | Meals · 2025-03-25 | Shingrix | $8 |
| Axsome Therapeutics | Meals · 2025-03-24 | Auvelity | $15 |
| Novo Nordisk | Meals · 2025-03-22 | None | $26 |
| Novo Nordisk | Meals · 2025-03-20 | Wegovy | $21 |
| Abiomed | Meals · 2025-03-13 | None | $30 |
| GlaxoSmithKline | Meals · 2025-02-28 | Shingrix | $8 |
| Amgen | Meals · 2025-02-28 | Repatha | $19 |
| Abbvie | Meals · 2025-02-27 | Vraylar | $17 |
| Abbvie | Meals · 2025-02-26 | Vraylar | $23 |
| Lilly USA | Meals · 2025-02-25 | Jardiance | $16 |
| Seqirus USA | Meals · 2025-02-18 | Flucelvax | $14 |
| Lilly USA | Meals · 2025-02-10 | Mounjaro | $14 |
| Abbvie | Meals · 2025-01-31 | Vraylar | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-30 | Kerendia | $19 |
| Xeris Pharmaceuticals | Meals · 2025-01-30 | Recorlev | $19 |
| Amgen | Meals · 2025-01-22 | Otezla | $7 |
| Pfizer | Meals · 2025-01-16 | Nurtec Odt | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-09 | Airsupra | $84 |
| Abbvie | Meals · 2025-01-08 | Vraylar | $15 |
| Abbvie | Meals · 2025-01-07 | Vraylar | $15 |
See earlier years (2024, 2023, 2022)
2024: $1,928
| Abbvie | Vraylar | $342 | 20 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $216 | 4 payments
|
| Lilly USA | Mounjaro | $174 | 12 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $159 | 16 payments
|
| Pfizer | Nurtec Odt | $148 | 10 payments
|
| Abiomed | Impella | $139 | 6 payments
|
| Novo Nordisk | Ozempic | $113 | 6 payments
|
| Otsuka America Pharmaceutical | Rexulti | $64 | 3 payments
|
| ViiV Healthcare | Dovato | $57 | 2 payments
|
| Amgen | Evenity | $56 | 3 payments
|
| Phathom Pharmaceuticals | Voquezna | $53 | 3 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Rexulti | $46 | 2 payments
|
| Esperion Therapeutics | Nexletol | $38 | 2 payments
|
| Aimmune Therapeutics | Zenpep | $33 | 2 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $32 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $30 | 2 payments
|
| Daiichi Sankyo | Injectafer | $25 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $25 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $24 | 1 payment
|
| Lundbeck | Rexulti | $23 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $22 | 1 payment
|
| Radius Health | None | $21 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $20 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $20 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $17 | 1 payment
|
| Merck Sharp & Dohme | None | $15 | 1 payment
|
2023: $1,809
| Lilly USA | Mounjaro | $257 | 22 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $185 | 17 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $153 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $147 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $141 | 7 payments
|
| Esperion Therapeutics | Nexletol | $113 | 6 payments
|
| Pfizer | Comirnaty | $80 | 5 payments
|
| AbbVie | Vraylar | $79 | 4 payments
|
| Novo Nordisk | Wegovy | $72 | 4 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $69 | 4 payments
|
| Amgen | Evenity | $61 | 3 payments
|
| Nestle Healthcare Nutrition | Zenpep | $61 | 3 payments
|
| Dynavax Technologies | Heplisav-B | $49 | 2 payments
|
| Kowa Pharmaceuticals America | Seglentis | $42 | 2 payments
|
| Otsuka Pharmaceutical Development & Commercialization | None | $38 | 2 payments
|
| Lundbeck | Rexulti | $34 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $34 | 2 payments
|
| Daiichi Sankyo | Injectafer | $27 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $22 | 1 payment
|
| Iti | Caplyta | $22 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $21 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $21 | 1 payment
|
| GlaxoSmithKline | Shingrix | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $15 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent | $14 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $13 | 1 payment
|
2022: $473
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $121 | 10 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $68 | 4 payments
|
| Dynavax Technologies | Heplisav-B | $39 | 2 payments
|
| Kowa Pharmaceuticals America | Seglentis | $34 | 2 payments
|
| SK Life Science | Xcopri | $30 | 1 payment
|
| Abbvie | Ubrelvy | $28 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $26 | 1 payment
|
| Lilly USA | Mounjaro | $25 | 2 payments
|
| Pfizer | Prevnar 20 | $23 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $22 | 1 payment
|
| Amgen | Otezla | $22 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $17 | 1 payment
|
Professional record
- NPI
- 1225491400
- Licence
- CA A170483California A170483: Current · expires 2028-10-31
- Trained
- Texas A & M University System, Hsc, College of Medicine, 2015 · 11 years ago
- Group
- Smartcare Medical Group, Inc · Vitalize Behavioral Health and Psychometrics Inc. · Community Health Partners
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Psychiatry (2084P0800X)
- Mailing address
- 255 W Herndon Ave Ste 103, Clovis, CA, 93612
- NPI first listed
- 2016-04-04
- NPI last updated
- 2025-05-01
- NPI record certified
- 2025-05-01
This is when the NPI record was last certified, not a medical board exam.